Ken Kelly
Plus aucun poste en cours
Profil
Mr. Kelly currently serves on the Boards of several biotech and medical device companies (CODA Genomics (an LSA company) EndoNav, Halozyme Therapeutics, MPEX Pharmaceuticals, NovaShunt, Solus Biosystems, and StemCor Systems).
He also provides strategic advice to EndoVx, ForteBio, and others.
Previously, he was the founder/CEO and Chairman at IntraBiotics Pharmaceuticals, which he took public in 2000.
He participated in the startup financing of over two dozen biotech and medical device companies while a General Partner at Latterell Venture Partners (LVP) and earlier as a Senior Associate at Institutional Venture Partners (IVP).
He was also a consultant for McKinsey & Company and a scientist at Integrated Genetics (acquired by Genzyme).
He has an MBA from Stanford and a BA in biochemical sciences from Harvard.
Anciens postes connus de Ken Kelly
| Sociétés | Poste | Fin |
|---|---|---|
Life Science Angels
 Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California. | Directeur/Membre du Conseil | 30/06/2007 |
Formation de Ken Kelly
| Stanford University | Masters Business Admin |
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Life Science Angels
Life Science Angels Investment ManagersFinance Life Science Angels (Life Science Angels) is a venture capital subsidiary of Life Science Angels, Inc. founded in 2004 by Allan W. May, Greg B. Scott and J. Casey McGlynn. The firm is headquartered in Sunnyvale, California. | Finance |
